Covid-19 Impact on Antacids Market, Global Research Reports 2020-2021
Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.
This report provides a complete quantitative data and qualitative analysis on the global market for Antacids. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Antacids was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Antacids is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Antacids, including the following market information:
Global Antacids Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Antacids Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Antacids Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Antacids Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (MT)
Key market players
Major competitors identified in this market include AstraZeneca, Takeda Pharmaceutical, Pfizer, Reckitt Benckiser, Bayer, Procter＆Gamble, GlaxoSmithKline, Johnson＆Johnson, CONBA, Xiuzheng Pharma, Sanofi, Bausch Health, CR SANJIU, Reddy'sLaboratories, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Proton Pump Inhibitor
H2 Antagonist
Acid Neutralizers
Based on the Application:
Rx Drug
OTC Drug
This report provides a complete quantitative data and qualitative analysis on the global market for Antacids. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Antacids was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Antacids is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Antacids, including the following market information:
Global Antacids Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Antacids Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Antacids Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Antacids Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (MT)
Key market players
Major competitors identified in this market include AstraZeneca, Takeda Pharmaceutical, Pfizer, Reckitt Benckiser, Bayer, Procter＆Gamble, GlaxoSmithKline, Johnson＆Johnson, CONBA, Xiuzheng Pharma, Sanofi, Bausch Health, CR SANJIU, Reddy'sLaboratories, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Proton Pump Inhibitor
H2 Antagonist
Acid Neutralizers
Based on the Application:
Rx Drug
OTC Drug
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
